Study of Vitamin C, Vitamin E and Their Combination to Treat Restless Legs Syndrome in Hemodialysis Patients (ShirazUMS)
Restless Legs Syndrome, Kidney Failure, Chronic
About this trial
This is an interventional treatment trial for Restless Legs Syndrome focused on measuring Dialysis, Restless legs syndrome, Ascorbic acid, Vitamin E
Eligibility Criteria
Inclusion Criteria:
- Patients who fulfill Restless leg syndrome international criteria(IRLSSG)
- Patients who are stable on HD without any internment illness or admission
Exclusion Criteria:
- Patients who have renal stone
- Patients who receive medications with RLS aggravating or alleviating properties
Sites / Locations
- Shiraz University of Medical Sciences
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Placebo Comparator
Vitamin C & Vitamin E.
Vitamin C & Placebo
Vitamin E & Placebo
Double Placebo
The patients in this arm received one tablet of vitamin C (200 mg) and one capsule of vitamin E (400 mg) daily for 8 weeks
The patients in this arm received one tablet of vitamin C (200 mg) and one placebo capsule daily for 8 weeks.
The patients in this arm received one capsule of vitamin E (400 mg) and one placebo tablet daily for 8 weeks.
The patients in this arm received one placebo capsule and one placebo tablet daily for 8 weeks.